microdosing glp-1 menopause for Perimenopause and Menopause: A Hormone-Aware Metabolic Framework What is GLP-1 microdosing?

Many may need to continue taking GLP-1 medications in order to maintain their weight loss and health goals The doses of medication may stay the same or may be reduced to find the lowest effective dose that maintains weight and health Lifestyle and behavioural changes in the maintenance phase are crucial Any reduction or stopping of GLP-1 medication should be done under medical supervision, gradually Monitor weight and appetite vigilantly Many people will find that they can use a reduced dose of GLP-1 medication once they have achieved their target BMI

Exogenously delivered acetyl-l-carnitine is endowed with neuroprotective and neurotrophic actions due to its antioxidant and metabolic properties

Junutula, J.R., et al., Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index